지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
이용수
INTRODUCTION
PANCREATIC CANCER BIOLOGY
NEUTROPHIL TO LYMPHOCYTE RATIO(NLR) AND PLATELET TO LYMPHOCYTE RATIO (PLR)
CHEMOTHERAPY
RADIATION THERAPY
IMMUNOTHERAPIES IN PANCREATIC CANCER
VASCULAR RESECTIONS
DISCUSSION
REFERENCES
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
Advances in neoadjuvant therapy for resectable pancreatic cancer over the past two decades
Annals of Hepato-Biliary-Pancreatic Surgery
2021 .05
Response to Neoadjuvant Therapy and Prognosis in Patients with Resectable Pancreatic Cancer: A Propensity Score Matching Analysis
Gut and Liver
2022 .01
Role of neoadjuvant treatment for resectable pancreatic ductal adenocarcinoma
한국간담췌외과학회 학술대회지
2017 .03
Validation of anatomical and biological definition of borderline resectable cancer according to the 2017 international consensus for survival in patients with resectable and borderline resectable pancreatic ductal adenocarcinoma undergoing upfront surgery
대한임상종양학회 학술대회지
2022 .02
Is Neoadjuvant Therapy Needed in Patients with Resectable Pancreatic Cancer?
Gut and Liver
2022 .01
Does Current Staging System Applicable for Borderline Resectable or Locally Advanced Pancreatic Cancer after Neoadjuvant Chemotherapy?
대한외과학회 학술대회 초록집
2022 .05
The change of clinical stage after neoadjuvant chemotherapy in prediction of prognosis for borderline resectable and locally advanced pancreatic cancer
Annals of Hepato-Biliary-Pancreatic Surgery
2021 .12
Optimal timing of surgical resection after neoadjuvant chemoradiation in borderline and locally advanced pancreatic ductal adenocarcinoma
Annals of Hepato-Biliary-Pancreatic Surgery
2021 .12
Optimal Timing of Surgical Resection After Neoadjuvant Chemoradiation in Borderline and Locally Advanced Pancreatic Ductal Adenocarcinoma
대한외과학회 학술대회 초록집
2021 .11
A phase 2 trial of neoadjuvant modified folfirinox chemotherapy for resectable pancreatic adenocarcinoma
Annals of Hepato-Biliary-Pancreatic Surgery
2022 .12
Current status of neoadjuvant therapy for pancreas cancer
대한임상종양학회 학술대회지
2021 .06
Updates of Chemotherapy and Radiotherapy for Pancreatic Cancer
대한췌담도학회지
2020 .01
Could computed tomography predict vascular R0 resection in patients with borderline and locally advanced pancreatic adenocarcinoma after neoadjuvant chemotherapy?
Annals of Hepato-Biliary-Pancreatic Surgery
2022 .12
Clinical benefit of neoadjuvant treatment for borderline resectable PDAC based on RCT
한국간담췌외과학회 학술대회지
2017 .03
Role of Neoadjuvant Chemotherapy in the Management of Advanced Ovarian Cancer
Asian Pacific journal of cancer prevention : APJCP
2015 .01
The decrease or normalization of carbohydrate antigen 19-9 have comparable prognostic performance in patients with borderline resectable and locally advanced pancreatic cancer after neoadjuvant chemotherapy
대한외과학회 학술대회 초록집
2019 .10
The Role of Neoadjuvant Treatment in Resectable Pancreatic Cancer
대한외과학회 학술대회 초록집
2019 .10
Radiological response pattern and patient survival in patients undergoing neoadjuvant chemotherapy
대한외과학회 학술대회 초록집
2019 .10
Corrigendum to: Is Neoadjuvant Therapy Needed in Patients with Resectable Pancreatic Cancer?
Gut and Liver
2023 .03
The comparison of short-term postoperative outcomes between upfront surgery and surgery following neoadjuvant treatment in pancreatic ductal adenocarcinoma
Annals of Hepato-Biliary-Pancreatic Surgery
2021 .12
0